Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a
✍ Scribed by Davide Eletto; Giuseppe Russo; Giovanni Passiatore; Luis Del Valle; Antonio Giordano; Kamel Khalili; Elisa Gualco; Francesca Peruzzi
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 498 KB
- Volume
- 216
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
MicroRNAs (miRs) are short endogenous RNAs that regulate gene expression by incomplete pairing with messenger RNAs. An increasing number of studies show that mammalian microRNAs play fundamental roles in various aspects of cellular function including differentiation, proliferation, and cell death. Recent findings demonstrating the presence of microRNAs in mature neuronal dendrites suggest their possible involvement in controlling local protein translation and synaptic function. HIV‐1 Encephalopathy (HIVE) is a manifestation of HIV‐1 infection that often results in neuronal damage and dysfunction. While neurons are rarely, if ever, infected by HIV‐1, they are exposed to cytotoxic viral and cellular factors including the HIV‐1 transactivating factor Tat. In this study, we show that Tat deregulates expression levels of selected microRNAs, including the neuronal mir‐128, in primary cortical neurons. We further show that mir‐128a inhibits expression of the pre‐synaptic protein SNAP25, whereas the anti‐mir‐128a partially restores Tat/mir‐128a‐induced downregulation of SNAP25 expression. Altogether, our data provide a novel mechanism by which HIV‐Tat perturbs neuronal activity. J. Cell. Physiol. 216: 764–770, 2008, © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Previous reports indicate that Genistein, a naturally occurring isoflavonoid, exhibits strong antiangiogenic activity. The underlying mechanism of inhibition, however, remains unclear. Among the biologic effects of Genistein are the inhibition of tyrosine kinases and the
Recombinant human interleukin-1 beta, a mediator of osteoblastic cell function, was found to regulate the expression of the cell adhesion receptors, integrins, on human osteosarcoma cells. Interleukin-1 beta (IL-1 beta) at picomolar concentrations, specifically elevated approximately six- to tenfold